Maurits Geerlings

Company: NanoCell Therapeutics

Job title: Co-Founder, President & CEO

Seminars:

Non-Viral Vectors Delivering Stably Integrating DNA for In Vivo CAR T Therapy 1:00 pm

Understanding the complexities of cell-targeted lipid nanoparticles, co-loaded with DNA and RNA for in vivo cell engineering Exploring manufacturing scalability for drug substances and drug product Strategies for mitigating toxicities and for maximizing treatment effectRead more

day: Day Two

Panel Discussion: ‘Evaluating LVV & LNP Delivery Method Clinical Potential in In Vivo Cell & Gene Therapies 2:00 pm

Discussing the long-term efficacy and durability of LVV and LNP-based therapies to understand the impact of delivery on disease regression and treatment Exploring how LVV, LNP and RNP technologies can evolve to produce enhanced therapeutic outcomes Evaluating the potential of the delivery vehicles to deliver complex payloadsRead more

day: Day Two